Siemens India Q2 FY 2024 Results: Strong Revenue and Profit Growth
Siemens India Q2 FY 2024 Quarterly Review
Financial Performance Overview
Siemens India has reported a robust performance for the second quarter of the fiscal year 2024 (Q2 FY 2024), showcasing significant growth across key financial metrics. Here’s a comparative analysis of Q2 FY 2024 with Q2 FY 2023 and Q1 FY 2024:
Financial Performance Overview
| Metrics | Q2 FY 2024 | Q1 FY 2024 | Q2 FY 2023 |
|---|---|---|---|
| Revenue (Rs. Cr) | 6,461 | 5,204 | 5,808 |
| Net Profit (Rs. Cr) | 831 | 578 | 572 |
| Profit Margin (%) | 15.00 | 13.00 | 12.00 |
| Other Income (Rs. Cr) | 283 | 157 | 146 |
| Earnings per Share (Rs.) | 23.33 | 16.22 | 16.04 |
Key Highlights
Revenue Growth: Siemens India’s revenue for Q2 FY 2024 rose to Rs. 6,461 crore, marking an 11.25% increase compared to Q2 FY 2023’s Rs. 5,808 crore, and a 24.2% rise from Q1 FY 2024’s Rs. 5,204 crore. This significant growth is attributed to enhanced operational efficiency and higher income from both core and non-core activities.
Net Profit Surge: The net profit for Q2 FY 2024 was Rs. 831 crore, demonstrating a 45% increase from Q2 FY 2023’s Rs. 572 crore and a 43.8% increase from Q1 FY 2024’s Rs. 578 crore. This surge indicates improved profitability and effective cost management.
Profit Margin Improvement: The profit margin improved to 15.00% in Q2 FY 2024, compared to 12.00% in Q2 FY 2023 and 13.00% in Q1 FY 2024. The enhancement in profit margin reflects better operational efficiency and reduced expenses.
Other Income: Other income in Q2 FY 2024 almost doubled to Rs. 283 crore, compared to Rs. 146 crore in Q2 FY 2023 and a notable rise from Rs. 157 crore in Q1 FY 2024. This significant increase in other income indicates Siemens India’s ability to generate additional revenue from non-core activities.
Earnings per Share (EPS): The EPS for Q2 FY 2024 stood at Rs. 23.33, showing an improvement from Rs. 16.04 in Q2 FY 2023 and Rs. 16.22 in Q1 FY 2024. This reflects the company’s stronger financial health and its commitment to delivering value to shareholders.